Objective: To present management options for gynaecomastia and mastodynia associated with nonsteroidal antiandrogen therapy, supported by relevant data and case studies. Background: Gynaecomastia ...

The PSMAddition trial shows 177Lu PSMA-617 significantly delays progression in mHSPC when added to hormone therapy, with a ...

A prospective study of sex hormone use in patients seeking transgender treatments suggests how these hormones may influence kidney health.

Finally, there are antiandrogen treatments, which work by stopping the body from using androgens, the male sex hormones. The recommendations made by Gauke would propose using antiandrogen ...

The first measures the ability of cells to grow in low androgen concentrations; the second measures growth in the presence of the antiandrogen bicalutamide. As expected, LNCaP cells infected with ...

It can be done in several ways. For instance, if you have had surgery to remove your testicles, your doctor may suggest that you begin taking an antiandrogen. If you have been using combination ...

In the randomized dose-expansion phase of a Phase 1 study (NCT03460977), the combination of mevrometostat (1250 mg twice daily on an empty stomach) and enzalutamide (160 mg once daily) demonstrated ...

antagonizes luminal lineage identity, and alters response to antiandrogen therapy in prostate cancer.

Consequently, when designing and analysing clinical trials for I/O and antiandrogen combination, it is indispensable to include stratification based on biological sex, along with other variables such ...

It can be used as monotherapy but also as part of a multimodal treatment regimen as well.” Cliff concurred that the scope for the use of topical antiandrogen in daily clinical practice could be ...